Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junichi Azuma

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
Drug Metabolism and Pharmacokinetics|March 17, 2005
Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLEMasanori Kubo, Toshiko Koue, Atsuhiro Inaba, et al.
Advances in Experimental Medicine and Biology|December 13, 2006
TauT gene expression is regulated by TonEBP and plays a role in cell survivalTakashi Ito, Yasushi Fujio, Yoriko Uozumi, et al.
European Journal of Clinical Pharmacology|August 26, 2003
Impact of CYP2D6*10 on mexiletine pharmacokinetics in healthy adult volunteersMasahiro Otani, Tsuyoshi Fukuda, Masakazu Naohara, et al.
Modern Rheumatology|November 4, 2008
Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapyNorihiro Nishimoto, Nobuyuki Miyasaka, Kazuhiko Yamamoto, et al.
Biochemical Pharmacology|August 9, 2002
Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cellsKyoko Takahashi, Xinshou Ouyang, Katsuko Komatsu, et al.
Neuropsychobiology|March 12, 2008
No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depressionMasaki Kato, Masataka Wakeno, Gaku Okugawa, et al.
Biochemical and Biophysical Research Communications|November 5, 2002
Identification of the novel splicing variants for the hPXR in human liversShuichi Fukuen, Tsuyoshi Fukuda, Hideyasu Matsuda, et al.
Pharmacogenetics|June 4, 2002
Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese populationShuichi Fukuen, Tsuyoshi Fukuda, Hiromi Maune, et al.
Drug Metabolism and Pharmacokinetics|April 28, 2005
The frequency of candidate alleles for CYP2D6 genotyping in the Japanese population with an additional respect to the -1584C to G substitutionYuka Ikenaga, Tsuyoshi Fukuda, Kazuhiro Fukuda, et al.
Journal of Ethnopharmacology|September 20, 2011
Andrographolide inhibits the expression and metabolic activity of cytochrome P450 3A4 in the modified Caco-2 cellsFeng Qiu, Xiao-Long Hou, Kyoko Takahashi, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
Drug Metabolism and Pharmacokinetics|March 17, 2005
Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLEMasanori Kubo, Toshiko Koue, Atsuhiro Inaba, et al.
Advances in Experimental Medicine and Biology|December 13, 2006
TauT gene expression is regulated by TonEBP and plays a role in cell survivalTakashi Ito, Yasushi Fujio, Yoriko Uozumi, et al.
European Journal of Clinical Pharmacology|August 26, 2003
Impact of CYP2D6*10 on mexiletine pharmacokinetics in healthy adult volunteersMasahiro Otani, Tsuyoshi Fukuda, Masakazu Naohara, et al.
Modern Rheumatology|November 4, 2008
Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapyNorihiro Nishimoto, Nobuyuki Miyasaka, Kazuhiko Yamamoto, et al.
Biochemical Pharmacology|August 9, 2002
Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cellsKyoko Takahashi, Xinshou Ouyang, Katsuko Komatsu, et al.
Neuropsychobiology|March 12, 2008
No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depressionMasaki Kato, Masataka Wakeno, Gaku Okugawa, et al.
Biochemical and Biophysical Research Communications|November 5, 2002
Identification of the novel splicing variants for the hPXR in human liversShuichi Fukuen, Tsuyoshi Fukuda, Hideyasu Matsuda, et al.
Pharmacogenetics|June 4, 2002
Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese populationShuichi Fukuen, Tsuyoshi Fukuda, Hiromi Maune, et al.
Drug Metabolism and Pharmacokinetics|April 28, 2005
The frequency of candidate alleles for CYP2D6 genotyping in the Japanese population with an additional respect to the -1584C to G substitutionYuka Ikenaga, Tsuyoshi Fukuda, Kazuhiro Fukuda, et al.
Journal of Ethnopharmacology|September 20, 2011
Andrographolide inhibits the expression and metabolic activity of cytochrome P450 3A4 in the modified Caco-2 cellsFeng Qiu, Xiao-Long Hou, Kyoko Takahashi, et al.
Pageof 14